Literature DB >> 1350264

Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 beta.

G de Saint Basile1, L D Notarangelo, C Bonaiti-Pellié, M Doussau, O Prolini, I W Craig, A Ugazio, C Griscelli, A Fischer.   

Abstract

Whole-blood cells of obligate carriers of the X-linked Wiskott-Aldrich syndrome (WAS) exhibit nonrandom inactivation of the X-chromosomes. However, because of the limited polymorphism of the probes available, the X-methylation pattern can only be determined in a restricted proportion of females. We thus analysed a large set of normal females and members of WAS families, using the recently described marker M27 beta, which detects the hyperpolymorphic locus DXS255. The probe was used to detect differences in methylation between the active and inactive X-chromosome, and the findings were compared with the pattern obtained using the well-documented probes from the 5' end of the PGK and HPRT genes. All the normal females were found to use either X-chromosome randomly, and there was complete correlation between the three probes in the populations studied. Segregation analysis performed with M27 beta and other related markers in the WAS families was fully in accordance with the X-inactivation data. The use of M27 beta, for both X-inactivation and segregation analysis of WAS kindreds, provides a basis for genetic counselling in the majority of families, including those with no surviving males.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350264     DOI: 10.1007/bf00217127

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome.

Authors:  B Arveiler; G de Saint-Basile; A Fischer; C Griscelli; J L Mandel
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

2.  Isolation and characterization of a human variable copy number tandem repeat at Xcen-p11.22.

Authors:  N J Fraser; Y Boyd; I Craig
Journal:  Genomics       Date:  1989-07       Impact factor: 5.736

3.  Active X chromosome DNA is unmethylated at eight CCGG sites clustered in a guanine-plus-cytosine-rich island at the 5' end of the gene for phosphoglycerate kinase.

Authors:  D H Keith; J Singer-Sam; A D Riggs
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

4.  Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome.

Authors:  G de Saint Basile; B Arveiler; N J Fraser; Y Boyd; I W Graig; G Griscelli; A Fischer
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

5.  Linkage studies of the Wiskott-Aldrich syndrome: polymorphisms at TIMP and the X chromosome centromere are informative markers for genetic prediction.

Authors:  W L Greer; M M Mahtani; P C Kwong; L A Rubin; M Peacocke; H F Willard; K A Siminovitch
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

6.  Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome.

Authors:  M Peacocke; K A Siminovitch
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 7.  X-chromosome inactivation and developmental patterns in mammals.

Authors:  M F Lyon
Journal:  Biol Rev Camb Philos Soc       Date:  1972-01

8.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  DNA polymorphisms, identified by an X-chromosome short-arm probe L 1.28 (DXS7), in different racial groups.

Authors:  S S Papiha; S S Bhattacharya; D F Roberts
Journal:  Hum Hered       Date:  1988       Impact factor: 0.444

10.  Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection.

Authors:  J T Prchal; A J Carroll; J F Prchal; W M Crist; H W Skalka; W J Gealy; J Harley; A Malluh
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

View more
  1 in total

1.  Is skewed X inactivation responsible for symptoms in female carriers for adrenoleucodystrophy?

Authors:  E Watkiss; T Webb; S Bundey
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.